IDM

Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise

OSAKA, Japan, and IRVINE, Calif., May 18 /PRNewswire-FirstCall/ -- Takeda Pharmaceutical Company Limited (TSE: 4502) and IDM Pharma, Inc. (Nasdaq: IDMI ) today announced that Takeda America Holdings, Inc., a wholly-owned subsidiary of Takeda (Takeda America), and IDM Pharma have enter...

IDM Pharma Reports First Quarter Financial Results

... IRVINE, Calif., May 11 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today reported fina...n presented represents the consolidated results of idm Pharma, Inc. and its subsidiary, idm Pharma S.A. Cash and cash equivalents was $...

IDM Pharma Receives Nasdaq Shareholder Equity Notification

...IRVINE, Calif., April 13 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ), a company focused ...ntinued listing on the Nasdaq Global Market. idm has until April 23, 2009 to provide Nasdaq a speci...et will be approved. As previously disclosed, idm has engaged JMP Securities, LLC, an investment ban...

Passlogix Introduces Industry's Fastest Sign-On to Kiosks with New Enhancements to v-GO Session Manager

...s. With more than 15 million licenses sold, the v-GO suite improves business efficiency, strengthens security and compliance, and dramatically reduces idm system deployment times. The company's patented technology - launched in 1996 with the market's first usable enterprise single sign-on solution - shor...

IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 Fiscal Year Containing Audit Opinion With Going Concern Qualification

... IRVINE, Calif., April 3 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ), a company focused ...ble merger or acquisition transaction. About idm Pharma idm Pharma is focused on the development of innovative...

IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma

...RVINE, Calif., March 9 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced tha...P. Walbert, president and chief executive officer, idm Pharma. "As our lead product candidate and first ...ceive approval, this is also a major milestone for idm Pharma. We look forward to amending the New Drug ...

IDM Pharma Joins NORD to Raise Awareness of Rare Diseases

... IRVINE, Calif., Feb. 26 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced tha...f research to develop diagnostics and treatments. idm Pharma is currently developing mifamurtide (MEPACT...rt W. Metz, vice president, commercial operations, idm Pharma. "Through our participation in Rare Diseas...

Horizon Therapeutics Names Timothy P. Walbert as President and CEO

...dustries. Mr. Walbert is currently president and chief executive officer of idm Pharma (Nasdaq: IDMI ), a biopharmaceutical company focused on the develop...novative products that activate the immune system to treat cancer. Prior to idm Pharma, Mr. Walbert served as executive vice president, commercial operatio...

IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic Osteosarcoma Treated with Mifamurtide (L-MTP-PE)

... IRVINE, Calif., June 2 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced the ...P. Walbert, president and chief executive officer, idm Pharma. "We continue to believe the data from non-...ion chemotherapy before and after surgery. About idm Pharma ...

IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting

... IRVINE, Calif., May 16 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced that...rently available at http://www.asco.org . About idm Pharma idm Pharma is focused on the development of innovative...

IDM in Medical Technology

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP)

...IRVINE, Calif., Sept. 26 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced that...P. Walbert, president and chief executive officer, idm Pharma. "We are pleased to report that, in respons...he final CHMP opinion now anticipated in November, idm Pharma expects a final decision from the European ...

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)

... IRVINE, Calif., July 1 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced that...P. Walbert, president and chief executive officer, idm Pharma. "We remain optimistic that we will have th...the CHMP opinion anticipated in the third quarter, idm Pharma expects a decision from the European Commis...

IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients

... IRVINE, Calif., June 2 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced foll...P. Walbert, president and chief executive officer, idm Pharma, Inc. About IDM-2101 IDM-2101 includes ...rkets (France, Germany, Italy, UK & Spain) About idm Pharma ...

IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program

... IRVINE, Calif., May 15 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (the Company) (Nasdaq: IDMI ) today ...P. Walbert, president and chief executive officer, idm Pharma. "The potential survival and quality of lif...ion chemotherapy before and after surgery. About idm Pharma ...

IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study

...IRVINE, Calif., March 20 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (the Company) (Nasdaq: IDMI ) announ...P. Walbert, president and chief executive officer, idm Pharma. "As we continue to navigate the U.S. and E...ion chemotherapy before and after surgery. About idm Pharma ...

IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology

... IRVINE, Calif., Feb. 4 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced the ...ion chemotherapy before and after surgery. About idm Pharma idm Pharma is focused on the development of innovative...

IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival

... IRVINE, Calif., Jan. 25 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced that...P. Walbert, president and chief executive officer, idm Pharma. "We are encouraged by CHMP's preliminary c...ion chemotherapy before and after surgery. About idm Pharma ...

IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company

... IRVINE, Calif., Dec. 14 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today provided an up...UVIDEM(R) and IDM-2101. Mifamurtide (L-MTP-PE) idm Pharma continues to work with European regulators ...P. Walbert, president and chief executive officer, idm Pharma. "Based on the current status of the lead p...

IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients

... IRVINE, Calif., Nov. 2 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced upda...lysis of data from the Phase 2 clinical trial with idm Pharma's cancer vaccine, UVIDEM, has demonstrated ...P. Walbert, president and chief executive officer, idm Pharma, Inc. "We are confident in the potential of...

IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients

... IRVINE, Calif., Nov. 2 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today announced upda...P. Walbert, president and chief executive officer, idm Pharma, Inc. "We will move forward with our plan t...arkets (France, Germany, Italy, UK & Spain) About idm Pharma ...

IDM in Medical Dictionary

Adhesion

...on of the iris to the lens can lead to glaucoma. ... MySpace Music profile for Adhesion . Download Adhesion Electronica / Experimental / idm music singles, watch music videos, listen to free streaming mp3s, & read ... The study of cell adhesion is part of cell biology. ... Cel...

IDM in Biological News

Fujitsu PalmSecure LOGONDIRECTOR Integrates with Passlogix v-GO Access Accelerator Suite

...s. With more than 10 million licenses sold, the v-GO suite improves business efficiency, strengthens security and compliance, and dramatically reduces idm system deployment times. The company's patented technology -- launched in 1996 with the market's first usable enterprise single sign-on solution -- sh...

Fujitsu PalmSecure LOGONDIRECTOR Integrates with Passlogix v-GO Access Accelerator Suite

...s. With more than 10 million licenses sold, the v-GO suite improves business efficiency, strengthens security and compliance, and dramatically reduces idm system deployment times. The company's patented technology -- launched in 1996 with the market's first usable enterprise single sign-on solution -- sh...

IDM in Biological Technology

Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer

...o-moderate pain in two Phase 3 studies. Dr. Sherman joins Horizon from idm Pharma, which was recently purchased by Takeda Pharmaceuticals Limited, whe...MTP-PE), a treatment for non-metastatic, resectable osteosarcoma. Prior to idm Pharma, Dr. Sherman served as vice president of clinical science at Takeda ...

Virtify, Inc. Delivers Industry's First Enterprise Content Compliance Software Suite for Life Sciences Companies

...ization information Virtx RMA - Web-based Resource Management and tracking Virtx ST - Submissions Tracking and planning Virtx idm - Investigator clinical trials management Virtx PRS - Patient Registry/clinical trial management Virtify is a featured solu...

IDM Pharma Reports 2008 Financial Results

...IRVINE, Calif., March 31 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) today reported fina...n presented represents the consolidated results of idm Pharma, Inc. and its subsidiary, idm Pharma S.A. Total revenues in the quarter end...

Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer

... and administration and chief financial officer of idm Pharma, Inc. (Nasdaq: IDMI ), a biopharmaceutical... and administration and chief financial officer of idm Pharma from August 2005 to March 2006, and was vic... from May 2000 until the business combination with idm Pharma in August 2005. Mr. De Vaere has also ser...

RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner

... from the University of Chicago and a B.S. in biology from Northern Illinois University. He currently serves as a member of the board of directors for idm Pharma (formerly Epimmune) and for Keel Pharmaceuticals. About RiverVest Venture Partners RiverVest Venture Partners is a venture capital firm inv...

IDM Pharma Appoints Gregory J. Tibbitts to Board of Directors

...E, Calif., April 4, 2008 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ) announced today the ...extensive financial experience will be an asset to idm Pharma's board of directors," said Timothy P. Walbert, president and chief executive officer of idm Pharma. "In senior positions at both privately-hel...

IDM Pharma to Present at BIOCOM Investor Conference

... IRVINE, Calif., Oct. 29 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ), a biotechnology com...resentation at http://www.idm-pharma.com . About idm Pharma idm Pharma is focused on the development of innovative...

IDM Pharma to Present at BIO InvestorForum in San Francisco

... IRVINE, Calif., Oct. 4 /PRNewswire-FirstCall/ -- idm Pharma, Inc. (Nasdaq: IDMI ), a biotechnology com...resentation at http://www.idm-pharma.com . About idm Pharma idm Pharma is focused on the development of innovative...

Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business

...ost recently served as Chairwoman of the Board for idm Pharma. Prior to idm Pharma, she was President & Chief Executive Office... addition to serving on the Board of Directors for idm Pharma, Thallion Pharmaceuticals and Cubist Pharma...

IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development

... IRVINE, Calif., Aug. 27 /PRNewswire-FirstCall/ -- idm Pharma (Nasdaq: IDMI) today announced that Jeffrey... pipeline, including UVIDEM and IDM-2101. He joins idm Pharma from Takeda Global Research & Development C... Walbert, President and Chief Executive Officer of idm Pharma, Inc. "In the near-term, Dr. Sherman will o...

IDM in Biological Dictionary

Proboscis

...boscis . Breakbeat • Glitchy • Glitchy • Funky • Electro • Techno • House • idm • Heavy ... Proboscis . Dope • Electro • Breakbeat • Midtempo • idm • Heavy ... Zoology information, history, articles and research from Aca...

Notochord

...ryology. 7. The Notochord ... a solid rod of cells—the notochord —which is then separated from the entoderm. ... Download Notochord Recordings idm / Ambient / Down-tempo music singles, watch ... Notochord , the record label, has been created to expand on this concept and ... The notochord i...

Monoculture

... singles, watch music videos, listen to free streaming mp3s, & read ... MySpace Music profile for MonoCulture . Download MonoCulture Indie / idm / Ambient music singles, watch music videos, listen to free streaming mp3s, & read ... Definition of monoculture from the Merriam-Webster Onl...